secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apimeds Pharmaceuticals US, Inc. (APUS)
CIK:        0001894525
Form:       8-K
Filed at:   2025-12-10T23:59:59+00:00
Accession:  0001213900-25-119894
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Two directors resign from Apimeds Pharmaceuticals board effective December 5, 2025
--------------------------------------------------------------------------------

- Dr. Vin Menon and Amir A. Dossal resigned from the Board of Directors on December 5, 2025.
- Resignations were not due to any disagreement with the company's operations, policies, or practices.
- Dr. Vin Menon remains CEO of the company; no replacements for the vacant board seats announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894525/000121390025119894/0001213900-25-119894-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894525/000121390025119894/ea0268648-8k_apimeds.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-119894

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer